NasdaqGS:VTRSPharmaceuticals
Is Buybacks And Higher 2026 Guidance Altering The Investment Case For Viatris (VTRS)?
In early August 2026, Viatris reported second-quarter results showing higher sales and revenue than a year earlier, while also completing a share repurchase program of 103,547,908 shares for about US$1.15 billion and affirming a quarterly dividend of US$0.12 per share.
The company paired this capital return with a modest increase to its 2026 revenue guidance midpoint to US$14.75 billion, suggesting management’s confidence in its operating direction despite reporting a second-quarter net...